Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy
- 1 March 2000
- journal article
- research article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 6 (1) , 3-10
- https://doi.org/10.1016/s1071-9164(00)80004-4
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart FailureNew England Journal of Medicine, 1998
- Restoring Function in Failing Hearts: The Effects of Beta BlockersThe American Journal of Medicine, 1998
- Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart FailureCirculation, 1996
- Medical Therapy Can Improve the Biological Properties of the Chronically Failing HeartCirculation, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group.Circulation, 1992
- Adrenergic effects on the biology of the adult mammalian cardiocyte.Circulation, 1992
- Effect of Oral Milrinone on Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1991
- Xamoterol in severe heart failureThe Lancet, 1990
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984